The role of targeting kinase activity by natural products in cancer chemoprevention and chemotherapy (Review)

Luo,Xiangjian; Yu,Xinfang; Liu,Sufang; Deng,Qipan; Liu,Xiaolan; Peng,Songling; Li,Hongde; Liu,Jikai; Cao,Ya

doi:10.3892/or.2015.4029

The role of targeting kinase activity by natural products in cancer chemoprevention and chemotherapy (Review)

Authors:
- Xiangjian Luo
- Xinfang Yu
- Sufang Liu
- Qipan Deng
- Xiaolan Liu
- Songling Peng
- Hongde Li
- Jikai Liu
- Ya Cao
View Affiliations

Affiliations: Cancer Research Institute, Xiangya School of Medicine, Central South University, Changsha, Hunan, P.R. China, State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, Yunnan, P.R. China
Published online on: June 4, 2015 https://doi.org/10.3892/or.2015.4029
Pages: 547-554

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The WHO clearly identifies tumors as a curable or a chronic disease. The use of natural agents in cancer prevention and therapy is currently playing an important role. Our laboratory has been investigating various natural phenolic compounds, including grifolin, neoalbaconol and epigallocatechin‑3-gallate (EGCG). In the present review, we focus on the anticancer activities and the molecular mechanisms of these compounds. Grifolin, a secondary metabolite isolated from the mushroom Albatrellus confluens, has been shown to inhibit cell growth and induce cell cycle arrest in multiple cancer cell lines by targeting extracellular signal-regulated kinase 1 or by upregulating death-associated protein kinase 1 (DAPK1) via p53. We also demonstrated that neoalbaconol, a novel small-molecular compound with a drimane-type sesquiterpenoid structure obtained from Albatrellus confluens, regulates cell metabolism by targeting 3-phosphoinositide-dependent protein kinase 1 (PDK1) and inhibits cancer cell growth. EGCG, a well known catechin found in tea, has gained much attention for its anticancer effects. Previously, we found that it regulates EBV lytic infection through the phosphoinositide-3 kinase/Akt (PI3K/Akt) and mitogen‑activated protein kinase (MAPK) pathways in EBV-positive cancer cells. Therefore, these natural agents could be used as potential leading compounds in the prevention of tumor progression and/or EBV-related cancer.

View Figures

View References

1	Cao Y, DePinho RA, Ernst M and Vousden K: Cancer research: Past, present and future. Nat Rev Cancer. 11:749–754. 2011. View Article : Google Scholar : PubMed/NCBI
2	Harvey A: The role of natural products in drug discovery and development in the new millennium. IDrugs. 13:70–72. 2010.PubMed/NCBI
3	Amin AR, Kucuk O, Khuri FR and Shin DM: Perspectives for cancer prevention with natural compounds. J Clin Oncol. 27:2712–2725. 2009. View Article : Google Scholar : PubMed/NCBI
4	Sarkar FH, Li Y, Wang Z and Kong D: Cellular signaling perturbation by natural products. Cell Signal. 21:1541–1547. 2009. View Article : Google Scholar : PubMed/NCBI
5	Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
6	Ye M, Liu JK, Lu ZX, Zhao Y, Liu SF, Li LL, Tan M, Weng XX, Li W and Cao Y: Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, inhibits tumor cell growth by inducing apoptosis in vitro. FEBS Lett. 579:3437–3443. 2005. View Article : Google Scholar : PubMed/NCBI
7	Ye M, Luo X, Li L, Shi Y, Tan M, Weng X, Li W, Liu J and Cao Y: Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, induces cell-cycle arrest in G1 phase via the ERK1/2 pathway. Cancer Lett. 258:199–207. 2007. View Article : Google Scholar : PubMed/NCBI
8	Luo XJ, Li LL, Deng QP, Yu XF, Yang LF, Luo FJ, Xiao LB, Chen XY, Ye M, Liu JK, et al: Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via p53 in nasopharyngeal carcinoma cells. Eur J Cancer. 47:316–325. 2011. View Article : Google Scholar
9	Luo XJ, Li W, Yang LF, Yu XF, Xiao LB, Tang M, Dong X, Deng QP, Bode AM, Liu JK, et al: DAPK1 mediates the G1 phase arrest in human nasopharyngeal carcinoma cells induced by grifolin, a potential antitumor natural product. Eur J Pharmacol. 670:427–434. 2011. View Article : Google Scholar : PubMed/NCBI
10	Deng Q, Yu X, Xiao L, Hu Z, Luo X, Tao Y, Yang L, Liu X, Chen H, Ding Z, et al: Neoalbaconol induces energy depletion and multiple cell death in cancer cells by targeting PDK1-PI3-K/Akt signaling pathway. Cell Death Dis. 4:e8042013. View Article : Google Scholar : PubMed/NCBI
11	Liu S, Li H, Chen L, Yang L, Li L, Tao Y, Li W, Li Z, Liu H, Tang M, et al: (-)-Epigallocatechin-3-gallate inhibition of Epstein- Barr virus spontaneous lytic infection involves ERK1/2 and PI3-K/Akt signaling in EBV-positive cells. Carcinogenesis. 34:627–637. 2013. View Article : Google Scholar
12	Song J, Manir MM and Moon SS: Cytotoxic grifolin derivatives isolated from the wild mushroom Boletus pseudocalopus (Basidiomycetes). Chem Biodivers. 6:1435–1442. 2009. View Article : Google Scholar : PubMed/NCBI
13	Hara T, Hirasawa A, Sun Q, Sadakane K, Itsubo C, Iga T, Adachi T, Koshimizu TA, Hashimoto T, Asakawa Y, et al: Novel selective ligands for free fatty acid receptors GPR120 and GPR40. Naunyn Schmiedebergs Arch Pharmacol. 380:247–255. 2009. View Article : Google Scholar : PubMed/NCBI
14	Jin S, Pang RP, Shen JN, Huang G, Wang J and Zhou JG: Grifolin induces apoptosis via inhibition of PI3K/AKT signalling pathway in human osteosarcoma cells. Apoptosis. 12:1317–1326. 2007. View Article : Google Scholar : PubMed/NCBI
15	Quang DN, Hashimoto T, Arakawa Y, Kohchi C, Nishizawa T, Soma G and Asakawa Y: Grifolin derivatives from Albatrellus caeruleoporus, new inhibitors of nitric oxide production in RAW 264. 7 cells. Bioorg Med Chem. 14:164–168. 2006. View Article : Google Scholar
16	Pelled D, Raveh T, Riebeling C, Fridkin M, Berissi H, Futerman AH and Kimchi A: Death-associated protein (DAP) kinase plays a central role in ceramide-induced apoptosis in cultured hippocampal neurons. J Biol Chem. 277:1957–1961. 2002. View Article : Google Scholar
17	Gozuacik D and Kimchi A: DAPk protein family and cancer. Autophagy. 2:74–79. 2006. View Article : Google Scholar : PubMed/NCBI
18	Raval A, Tanner SM, Byrd JC, Angerman EB, Perko JD, Chen SS, Hackanson B, Grever MR, Lucas DM, Matkovic JJ, et al: Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell. 129:879–890. 2007. View Article : Google Scholar : PubMed/NCBI
19	Hupp TR, Sparks A and Lane DP: Small peptides activate the latent sequence-specific DNA binding function of p53. Cell. 83:237–245. 1995. View Article : Google Scholar : PubMed/NCBI
20	Martoriati A, Doumont G, Alcalay M, Bellefroid E, Pelicci PG and Marine JC: dapk1, encoding an activator of a p19^ARF- p53-mediated apoptotic checkpoint, is a transcription target of p53. Oncogene. 24:1461–1466. 2005. View Article : Google Scholar
21	Nichols NM and Matthews KS: Human p53 phosphorylation mimic, S392E, increases nonspecific DNA affinity and thermal stability. Biochemistry. 41:170–178. 2002. View Article : Google Scholar : PubMed/NCBI
22	MacCorkle RA and Tan TH: Mitogen-activated protein kinases in cell-cycle control. Cell Biochem Biophys. 43:451–461. 2005. View Article : Google Scholar : PubMed/NCBI
23	Llambi F, Lourenço FC, Gozuacik D, Guix C, Pays L, Del Rio G, Kimchi A and Mehlen P: The dependence receptor UNC5H2 mediates apoptosis through DAP-kinase. EMBO J. 24:1192–1201. 2005. View Article : Google Scholar : PubMed/NCBI
24	Shang T, Joseph J, Hillard CJ and Kalyanaraman B: Death- associated protein kinase as a sensor of mitochondrial membrane potential: Role of lysosome in mitochondrial toxin-induced cell death. J Biol Chem. 280:34644–34653. 2005. View Article : Google Scholar : PubMed/NCBI
25	Chen X, Chi Y, Bloecher A, Aebersold R, Clurman BE and Roberts JM: N-acetylation and ubiquitin-independent proteasomal degradation of p21^Cip1. Mol Cell. 16:839–847. 2004. View Article : Google Scholar : PubMed/NCBI
26	Bloom J, Amador V, Bartolini F, DeMartino G and Pagano M: Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. Cell. 115:71–82. 2003. View Article : Google Scholar : PubMed/NCBI
27	Chen CH, Wang WJ, Kuo JC, Tsai HC, Lin JR, Chang ZF and Chen RH: Bidirectional signals transduced by DAPK-ERK interaction promote the apoptotic effect of DAPK. EMBO J. 24:294–304. 2005. View Article : Google Scholar :
28	Hellwig V, Nopper R, Mauler F, Freitag J, Liu J-K, Ding Z-H and Stadler M: Activities of prenylphenol derivatives from fruitbodies of Albatrellus spp. on the human and rat vanilloid receptor 1 (VR1) and characterisation of the novel natural product, confluentin. Arch Pharm. 336:119–126. 2003. View Article : Google Scholar
29	Liu Q, Shu X, Wang L, Sun A, Liu J and Cao X: Albaconol, a plant-derived small molecule, inhibits macrophage function by suppressing NF-kappaB activation and enhancing SOCS1 expression. Cell Mol Immunol. 5:271–278. 2008. View Article : Google Scholar : PubMed/NCBI
30	Fuchs Y and Steller H: Programmed cell death in animal development and disease. Cell. 147:742–758. 2011. View Article : Google Scholar : PubMed/NCBI
31	Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, et al: Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 19:107–120. 2012. View Article : Google Scholar :
32	Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA and Yuan J: Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 1:112–119. 2005. View Article : Google Scholar
33	Wu YT, Tan HL, Huang Q, Kim YS, Pan N, Ong WY, Liu ZG, Ong CN and Shen HM: Autophagy plays a protective role during zVAD-induced necrotic cell death. Autophagy. 4:457–466. 2008. View Article : Google Scholar : PubMed/NCBI
34	Bell BD, Leverrier S, Weist BM, Newton RH, Arechiga AF, Luhrs KA, Morrissette NS and Walsh CM: FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc Natl Acad Sci USA. 105:16677–16682. 2008. View Article : Google Scholar : PubMed/NCBI
35	Vivanco I and Sawyers CL: The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer. 2:489–501. 2002. View Article : Google Scholar : PubMed/NCBI
36	Toker A and Newton AC: Cellular signaling: Pivoting around PDK-1. Cell. 103:185–188. 2000. View Article : Google Scholar : PubMed/NCBI
37	Peifer C and Alessi DR: Small-molecule inhibitors of PDK1. Chem Med Chem. 3:1810–1838. 2008. View Article : Google Scholar : PubMed/NCBI
38	Yang CS, Wang H, Li GX, Yang Z, Guan F and Jin H: Cancer prevention by tea: Evidence from laboratory studies. Pharmacol Res. 64:113–122. 2011. View Article : Google Scholar : PubMed/NCBI
39	Link A, Balaguer F and Goel A: Cancer chemoprevention by dietary polyphenols: Promising role for epigenetics. Biochem Pharmacol. 80:1771–1792. 2010. View Article : Google Scholar : PubMed/NCBI
40	Leone M, Zhai D, Sareth S, Kitada S, Reed JC and Pellecchia M: Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res. 63:8118–8121. 2003.PubMed/NCBI
41	Li M, He Z, Ermakova S, Zheng D, Tang F, Cho YY, Zhu F, Ma WY, Sham Y, Rogozin EA, et al: Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigal-locatechin-3-gallate regulates cell transformation. Cancer Epidemiol Biomarkers Prev. 16:598–605. 2007. View Article : Google Scholar : PubMed/NCBI
42	Bode AM and Dong Z: Epigallocatechin 3-gallate and green tea catechins: united they work, divided they fail. Cancer Prev Res. 2:514–517. 2009. View Article : Google Scholar
43	Urusova DV, Shim JH, Kim DJ, Jung SK, Zykova TA, Carper A, Bode AM and Dong Z: Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1. Cancer Prev Res. 4:1366–1377. 2011. View Article : Google Scholar
44	Ramos S: Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways. Mol Nutr food Res. 52:507–526. 2008. View Article : Google Scholar : PubMed/NCBI
45	Kim JW, Amin AR and Shin DM: Chemoprevention of head and neck cancer with green tea polyphenols. Cancer Prev Res. 3:900–909. 2010. View Article : Google Scholar
46	Yang CS, Wang X, Lu G and Picinich SC: Cancer prevention by tea: Animal studies, molecular mechanisms and human relevance. Nat Rev Cancer. 9:429–439. 2009. View Article : Google Scholar : PubMed/NCBI
47	Singh BN, Shankar S and Srivastava RK: Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications. Biochem Pharmacol. 82:1807–1821. 2011. View Article : Google Scholar : PubMed/NCBI
48	Tsao AS, Liu D, Martin J, Tang XM, Lee JJ, El-Naggar AK, Wistuba I, Culotta KS, Mao L, Gillenwater A, et al: Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res. 2:931–941. 2009. View Article : Google Scholar
49	Steinmann J, Buer J, Pietschmann T and Steinmann E: Anti- infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea. Br J Pharmacol. 168:1059–1073. 2013. View Article : Google Scholar :
50	Satoh T, Hoshikawa Y, Satoh Y, Kurata T and Sairenji T: The interaction of mitogen-activated protein kinases to Epstein-Barr virus activation in Akata cells. Virus Genes. 18:57–64. 1999. View Article : Google Scholar : PubMed/NCBI
51	Darr CD, Mauser A and Kenney S: Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylino-sitol-3 kinase activation. J Virol. 75:6135–6142. 2001. View Article : Google Scholar : PubMed/NCBI
52	Zheng H, Li LL, Hu DS, Deng XY and Cao Y: Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol. 4:185–196. 2007.PubMed/NCBI
53	Zhao Y, Wang H, Zhao XR, Luo FJ, Tang M and Cao Y: Epigallocatechin-3-gallate interferes with EBV-encoding AP-1 signal transduction pathway. Zhonghua Zhong Liu Za Zhi. 26:393–397. 2004.In Chinese. PubMed/NCBI
54	Kanwar J, Taskeen M, Mohammad I, Huo C, Chan TH and Dou QP: Recent advances on tea polyphenols. Front Biosci. 4:111–131. 2012. View Article : Google Scholar